Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Veradigm Inc (MDRX)

OTC Markets
Currency in USD
Disclaimer
9.30
-0.20(-2.11%)
Delayed Data
MDRX Scorecard
Full Analysis
Stock generally trades with low price volatility
Fair Value
Day's Range
9.269.50
52 wk Range
5.5013.69
Prev. Close
9.5
Open
9.26
Day's Range
9.26-9.5
52 wk Range
5.5-13.69
Volume
6,971
Average Volume (3m)
273,121
1-Year Change
-31.51%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
MDRX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
12.25
Upside
+31.72%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Veradigm Inc Company Profile

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Compare MDRX to Peers and Sector

Metrics to compare
MDRX
Peers
Sector
Relationship
P/E Ratio
0.0x−5.6x−0.6x
PEG Ratio
0.00−0.060.00
Price/Book
0.0x0.5x2.6x
Price / LTM Sales
0.0x2.5x3.2x
Upside (Analyst Target)
0.0%28.0%48.5%
Fair Value Upside
Unlock24.8%7.8%Unlock

People Also Watch

20.50
PDCO
+1.74%
106.68
COO
+0.36%
256.31
NDSN
+1.07%
132.67
LAMR
+0.93%
33.550
FREG
-0.33%

FAQ

What Is the Veradigm (MDRX) Stock Price Today?

The Veradigm stock price today is 9.30

What Stock Exchange Does Veradigm Trade On?

Veradigm is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Veradigm?

The stock symbol for Veradigm is "MDRX."

What Is the Veradigm Market Cap?

As of today, Veradigm market cap is 1.57B.

What is Veradigm Earnings Per Share?

The Veradigm EPS is 0.527.

What Is the Next Veradigm Earnings Date?

Veradigm will release its next earnings report on Nov 01, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.